Atlas Trials

A Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Patients With Symptoms Of Overactive Bladder Including Nocturnal Urinary Urgency

Clinical trial NCT00911937 · COMPLETED

Trial details

NCT number
NCT00911937
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Overactive Bladder
Start date
2009-08-01
Primary completion
2011-09-01
Enrollment
963

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.